Lifevantage (NASDAQ: LFVN) reported Q4 EPS of $0.17, $0.01 better than the analyst estimate of $0.16. Revenue for the quarter came in at $55.1 million versus the consensus estimate of $56.88 million.

GUIDANCE:

Lifevantage sees FY2026 EPS of $1.00-$1.15, versus the consensus of $0.83. Lifevantage sees FY2026 revenue of $225-240 million, versus the consensus of $231.3 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.